Morgan Stanley SEC Filings

Bank of Montreal (BMO) is issuing US$6.196 million of Senior Medium-Term Notes, Series K – Autocallable Barrier Notes with Contingent Coupons – linked to Lam Research Corp. (LRCX) common stock.

• Contingent Coupon: 1.1925% monthly (≈14.31% p.a.) paid only if LRCX closes ≥ Coupon Barrier (67% of Initial Level, $65.12) on the relevant Observation Date.
• Automatic Redemption: Starting 30-Dec-2025, if LRCX closes > Initial Level on any Observation Date, the note is redeemed at par plus the coupon; no further payments occur.
• Maturity / Principal Risk: 03-Aug-2026. If not called and LRCX closes < Trigger Level (67% of Initial), investors lose 1% of principal for every 1% decline (down to zero). If LRCX stays ≥ Trigger Level, principal is returned.
• Issue Economics: Price to public 100%; estimated initial value $972.97 (≈97.3% of face) reflecting embedded fees/hedging. Agent’s commission 2.15%.
• Denomination & Liquidity: $1,000 minimum. Unlisted; secondary market, if any, only through BMOCM. Value sensitive to BMO credit spreads and market volatility.
• Credit & Tax: Unsecured BMO obligation; subject to BMO credit risk and complex U.S. tax treatment (pre-paid contingent income-bearing derivative).

The product targets investors seeking high conditional income and limited downside buffer, willing to forego upside above coupons, accept potential principal loss below a 33% decline, and tolerate issuer credit and liquidity risks.

Palo Alto Networks, Inc. (PANW) – Form 144 filing dated July 1, 2025 discloses a proposed secondary sale of 300,000 common shares by family-related trusts through J.P. Morgan Securities LLC. The shares carry an estimated aggregate market value of $61.392 million based on recent prices and represent approximately 0.05 % of the company’s 666.8 million shares outstanding, implying limited ownership dilution because no new shares are being issued.

The trusts involved (Hawk Family Trust and multiple Cliff Family Trust sub-accounts) have been active sellers. Over the previous three months they completed eight open-market transactions totaling ≈959,796 shares and $145.6 million in gross proceeds, with sales executed on 11-Apr-2025, 1-May-2025 and 2-Jun-2025. The forthcoming 300 k-share block would lift the rolling four-month total to roughly 1.26 million shares.

All sales are made pursuant to Rule 144, which permits resale of restricted or control securities subject to volume, manner-of-sale and notice requirements. The seller certifies that no undisclosed material adverse information is known and, if applicable, that any Rule 10b5-1 trading plan was adopted on the date indicated.

Investment takeaways:

• The filing signals continued insider-related supply but on a scale unlikely to materially affect PANW’s float or trading liquidity.
• Because these are secondary sales, no cash flows to the company; proceeds accrue solely to the trusts.
• Investors may nevertheless monitor insider sentiment, especially given the nine-month cadence of sizable disposals.

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) filed seven Post-Effective Amendments on Form S-8 to deregister all unsold shares previously registered for issuance under its 2019 employee equity plans. The action follows the closing of its merger with Merck KGaA, Darmstadt, Germany on 1 July 2025, under which SpringWorks became a wholly owned subsidiary of Merck through EMD Holdings Merger Sub, Inc.

The amendments cover the following historical S-8 registrations:

• Reg. Nos. 333-234365, 333-237350, 333-253531, 333-262996, 333-270096, 333-277380 and 333-285076.
• In aggregate, these filings had registered tens of millions of common shares for the 2019 Stock Option & Incentive Plan, the Amended & Restated 2019 Equity Incentive Plan and the 2019 Employee Stock Purchase Plan.

Because the company is now private, SpringWorks has terminated all offerings under these plans. Consistent with undertakings in each registration statement, any securities that remained unsold as of the merger date are withdrawn from registration. The filing is signed on behalf of the company by Secretary Michael MacDougall and relies on Rule 478 of the Securities Act to omit additional signatures.

The amendments are largely administrative, signalling the end of SpringWorks’ status as an independent public issuer and the cessation of share issuance under its legacy equity compensation and ESPP programmes.

Form 144 filing for Etsy, Inc. (ETSY) discloses the planned sale of 1,500 common shares at an estimated aggregate market value of $75,075. The filer intends to execute the transaction on or about 07/01/2025 through UBS Financial Services, Inc. on the NASDAQ exchange.

The same individual—identified by the address "117 Adam Street, Brooklyn, NY 11201"—has already sold 4,500 Etsy shares in the last three months (1,500 shares on each of 04/01/2025, 05/01/2025, and 06/02/2025) for total gross proceeds of $225,140.70.

With 104,282,256 shares outstanding, the new proposed sale represents roughly 0.0014 % of Etsy’s total shares, indicating minimal dilution or ownership impact. No relationship to the issuer or 10b5-1 trading plan details are provided, and the filer affirms no undisclosed material information.

For investors, the filing signals continued, small-scale insider selling; while not material to share count, it may be a sentiment data-point to monitor if selling accelerates or expands in size.

Morgan Stanley Finance LLC, guaranteed by Morgan Stanley (ticker MS), is marketing Worst-of INDU and SPX Dual Directional Market-Linked Notes maturing on August 1, 2030. The structured note allocates exposure to the worst performer of the Dow Jones Industrial Average (INDU) and the S&P 500 Index (SPX). Key economic terms include a 100% upside participation rate and a 100% “absolute return” participation on index declines of up to 20%. Positive index performance is capped at 137-140% of principal (maximum cash payment $1,370-$1,400). If the worst performing index closes below the 80% knock-out level on the single observation date (July 29, 2030), principal is fully at risk; the payment then reflects only the indexed return, potentially below par. The notes do not pay coupons and are not listed on any exchange.

The preliminary estimated value is $938.10 per $1,000 note—roughly 6% below issue price—highlighting built-in fees and hedging costs. Investors face issuer and guarantor credit risk, limited secondary liquidity, tax complexity and valuation determined by Morgan Stanley’s internal models. All payments occur at maturity and depend solely on the closing level of the worst index on the observation date; interim movements are irrelevant. The offering is made under Registration Statement Nos. 333-275587 and 333-275587-01, with pricing set for July 28, 2025.

Amendment No. 25 to Schedule 13D discloses that India-based Tractors & Farm Equipment Ltd (TAFE), TAFE Motors & Tractors Ltd and chair Mallika Srinivasan collectively hold roughly 16.3 % of AGCO’s 74.6 million outstanding shares (≈12.15 million shares). The filing follows a comprehensive settlement signed on 30 Jun 2025 that resets the long-standing strategic relationship between the two companies.

Key agreements

• Cooperation Agreement: imposes a perpetual stand-still: the Reporting Persons will vote in line with AGCO’s Board and will not raise their ownership above the “Ownership Cap” (≈16.3 %) except on defined change-of-control triggers. They must also participate proportionately in future AGCO buybacks.
• Buyback Agreement: AGCO Holding B.V. will sell its 20.7 % stake in TAFE (2.389 million shares) back to TAFE for US$260 million. Completion is pending Indian procedural approvals.
• Intellectual Property Agreement: Exclusive rights to the “Massey Ferguson” brand for tractors in India, Nepal and Bhutan will transfer to TAFE when the Buyback closes.
• Arbitration & Litigation Settlements: All cross-border disputes and brand-related suits will be withdrawn, eliminating legal overhang.

Strategic implications

• AGCO receives US$260 million cash and exits its minority position in TAFE.
• Stable 16 % shareholder alignment reduces near-term takeover risk and supports Board initiatives.
• Brand transfer limits AGCO’s direct exposure to the fast-growing Indian tractor market but clarifies marketing rights.

Offering overview: Morgan Stanley Finance LLC, guaranteed by Morgan Stanley (“MS”), is marketing five-year “Trigger PLUS” structured notes that settle on August 5, 2030. The notes are linked to the worst-performing of three U.S. equity benchmarks -- the S&P 500 (SPX), Nasdaq-100 (NDX) and Russell 2000 (RTY).

• Upside participation: Final payment equals principal plus 160%–175% of any positive performance of the worst index.
• Downside buffer: Principal is repaid in full as long as the worst index has not fallen more than 35 percent (i.e., it remains at or above 65 percent of its initial level) on the single observation date of July 31, 2030.
• Full downside exposure below the threshold: If that 65 percent trigger is breached, repayment equals principal multiplied by the worst index’s percentage return, generating dollar-for-dollar losses and potentially zero recovery.
• No interim coupons, no early call: Investors receive no periodic interest and their return depends solely on the final index levels.
• Credit & liquidity considerations: All cash flows rely on Morgan Stanley’s credit; the notes will not be listed, and MS expects limited secondary trading. The indicative estimated value is $943.40 versus the assumed $1,000 issue price, reflecting embedded fees and hedging costs.
• Key dates: Pricing - July 31, 2025  |  Observation - July 31, 2030  |  Maturity - August 5, 2030
• CUSIP: 61778NAZ4  |  Registration Nos.: 333-275587 / 333-275587-01

Investor take-away: The structure offers leveraged upside and a 35% buffer, but embeds significant risks: (i) worst-of design magnifies downside probability, (ii) principal is unprotected below the trigger, (iii) valuation is below par at issuance, (iv) tax treatment is uncertain, and (v) investors assume MS credit and secondary-market liquidity risk.

Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering SPUMP40 Contingent Income Memory Buffered Auto-Callable Securities due July 16, 2030. The notes are linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index (ticker SPUMP40).

Key commercial terms:

• Contingent coupon: at least 9.0% per annum, paid monthly, with a memory feature if the index closes ≥70% of its initial level on the relevant observation date.
• Automatic early redemption: monthly, starting after the first year, if the index closes at or above 90% of its initial level; investors then receive 100% principal plus accrued coupon.
• Downside exposure: a 15% buffer protects principal for index declines up to 15%. Below that, investors lose 1% of principal for each percentage point decline beyond the buffer, with a maximum loss of 85%.
• Estimated value: approximately $906 versus the $1,000 issue price, reflecting structuring and hedging costs.
• No listing; secondary liquidity will be limited and prices may be volatile.

Primary risks highlighted include (i) no participation in any index appreciation, (ii) reliance on Morgan Stanley’s credit, (iii) potential early redemption that caps income stream, (iv) the index’s limited operating history and 4% decrement drag, (v) uncertain U.S. tax treatment, and (vi) model-based valuation that may differ from secondary market pricing.

Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering SPUMP40 Contingent Income Memory Buffered Auto-Callable Securities due July 16, 2030. The notes are linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index (ticker SPUMP40).

Key commercial terms:

• Contingent coupon: at least 9.0% per annum, paid monthly, with a memory feature if the index closes ≥70% of its initial level on the relevant observation date.
• Automatic early redemption: monthly, starting after the first year, if the index closes at or above 90% of its initial level; investors then receive 100% principal plus accrued coupon.
• Downside exposure: a 15% buffer protects principal for index declines up to 15%. Below that, investors lose 1% of principal for each percentage point decline beyond the buffer, with a maximum loss of 85%.
• Estimated value: approximately $906 versus the $1,000 issue price, reflecting structuring and hedging costs.
• No listing; secondary liquidity will be limited and prices may be volatile.

Primary risks highlighted include (i) no participation in any index appreciation, (ii) reliance on Morgan Stanley’s credit, (iii) potential early redemption that caps income stream, (iv) the index’s limited operating history and 4% decrement drag, (v) uncertain U.S. tax treatment, and (vi) model-based valuation that may differ from secondary market pricing.